Lombard Odier Asset Management (Europe)’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $9.59M | Buy |
89,290
+63,655
| +248% | +$6.84M | 0.67% | 49 |
|
2025
Q1 | $2.59M | Buy |
+25,635
| New | +$2.59M | 0.21% | 113 |
|
2021
Q1 | – | Sell |
-19,680
| Closed | -$703K | – | 255 |
|
2020
Q4 | $703K | Buy |
19,680
+7,195
| +58% | +$257K | 0.04% | 159 |
|
2020
Q3 | $477K | Hold |
12,485
| – | – | 0.03% | 182 |
|
2020
Q2 | $438K | Hold |
12,485
| – | – | 0.06% | 113 |
|
2020
Q1 | $407K | Sell |
12,485
-2,420
| -16% | -$78.9K | 0.03% | 176 |
|
2019
Q4 | $674K | Hold |
14,905
| – | – | 0.05% | 155 |
|
2019
Q3 | $606K | Hold |
14,905
| – | – | 0.05% | 158 |
|
2019
Q2 | $641K | Hold |
14,905
| – | – | 0.05% | 153 |
|
2019
Q1 | $572K | Hold |
14,905
| – | – | 0.06% | 148 |
|
2018
Q4 | $527K | Buy |
14,905
+1,295
| +10% | +$45.8K | 0.05% | 154 |
|
2018
Q3 | $524K | Hold |
13,610
| – | – | 0.04% | 180 |
|
2018
Q2 | $445K | Hold |
13,610
| – | – | 0.03% | 187 |
|
2018
Q1 | $372K | Sell |
13,610
-2,505
| -16% | -$68.5K | 0.03% | 220 |
|
2017
Q4 | $399K | Sell |
16,115
-2,144
| -12% | -$53.1K | 0.03% | 226 |
|
2017
Q3 | $533K | Hold |
18,259
| – | – | 0.03% | 198 |
|
2017
Q2 | $506K | Hold |
18,259
| – | – | 0.03% | 200 |
|
2017
Q1 | $454K | Sell |
18,259
-2,676
| -13% | -$66.5K | 0.03% | 206 |
|
2016
Q4 | $453K | Hold |
20,935
| – | – | 0.16% | 165 |
|
2016
Q3 | $498K | Hold |
20,935
| – | – | 0.17% | 159 |
|
2016
Q2 | $489K | Buy |
+20,935
| New | +$489K | 0.03% | 193 |
|